Ross A Friedman

Title: Ross A Friedman: Innovator in Pharmaceutical Compositions

Introduction

Ross A Friedman is a notable inventor based in Washington, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral pharmaceutical compositions. His work focuses on enhancing the safety and efficacy of medications through innovative formulations.

Latest Patents

Friedman holds a patent for a solid oral pharmaceutical composition that includes alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor. This invention relates to a composition that comprises an active pharmaceutical ingredient, a nitrosamine inhibitor, and a pharmaceutically acceptable excipient. The nitrosamine inhibitor is designed to reduce the formation of nitrosamines, which can be harmful, thereby improving the safety profile of the pharmaceutical composition.

Career Highlights

Friedman is associated with Mylan Pharmaceuticals Inc., a leading global generic and specialty pharmaceuticals company. His work at Mylan has allowed him to contribute to the development of innovative pharmaceutical solutions that address critical health needs. With a focus on research and development, Friedman has played a key role in advancing the company's product offerings.

Collaborations

Friedman collaborates with various professionals in the pharmaceutical industry, including his coworker John D Kirsch. These collaborations enhance the research and development process, leading to more effective and safer pharmaceutical products.

Conclusion

Ross A Friedman is a dedicated inventor whose work in pharmaceutical compositions has the potential to significantly impact the industry. His innovative approach to reducing nitrosamine formation in medications exemplifies the importance of research and development in creating safer healthcare solutions.